title: Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis.
authors.forename: S
authors.initials: S
authors.lastname: Rajakulendran
authors.forename: K
authors.initials: K
authors.lastname: Gadsby
authors.forename: D
authors.initials: D
authors.lastname: Allen
authors.forename: S
authors.initials: S
authors.lastname: O'Reilly
authors.forename: C
authors.initials: C
authors.lastname: Deighton
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha